within Pharmacolibrary.Drugs.ATC.D;

model D07CB01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00025,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07CB01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone and antibiotics (ATC code D07CB01) is a combination topical medication containing the corticosteroid triamcinolone with one or more antibiotics, intended for use in treatment of mixed dermatoses that have an inflammatory and bacterial component, such as infected eczema or dermatitis. The combination is usually approved for short-term use on the skin, mainly for dermatological purposes, to reduce inflammation and treat or prevent secondary bacterial infections.</p><h4>Pharmacokinetics</h4><p>No specific pharmacokinetic data is published on the fixed combination of topical triamcinolone with antibiotics under ATC D07CB01. Pharmacokinetic parameters for such topical combinations are generally not well characterized in the literature.</p><h4>References</h4><ol><li><p>Yi, NY, et al., &amp; Gilger, BC (2008). Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes. <i>Veterinary ophthalmology</i> 11 Suppl 1 15–19. DOI:<a href=&quot;https://doi.org/10.1111/j.1463-5224.2008.00636.x&quot;>10.1111/j.1463-5224.2008.00636.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19046265/&quot;>https://pubmed.ncbi.nlm.nih.gov/19046265</a></p></li><li><p>Vickers, CF (1972). Stratum corneum reservoir for drugs. <i>Advances in biology of skin</i> 12 177–189. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4579191/&quot;>https://pubmed.ncbi.nlm.nih.gov/4579191</a></p></li><li><p>Stoughton, RB (1982). Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. <i>Archives of dermatology</i> 118(7) 474–477. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7092271/&quot;>https://pubmed.ncbi.nlm.nih.gov/7092271</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07CB01;
